0
Clinical Investigations: COPD |

Mid-Arm Muscle Area Is a Better Predictor of Mortality Than Body Mass Index in COPD*

Juan José Soler-Cataluña, MD; Lourdes Sánchez-Sánchez, MD; Miguel Ángel Martínez-García, MD; Pilar Román Sánchez, MD; Emmanuel Salcedo, MD; Miriam Navarro, MD
Author and Funding Information

*From the Unidad de Neumología (Drs. Soler-Cataluña and Martínez-García), Hospital General de Requena (Drs. Sánchez-Sánchez, Sánchez, Salcedo, and Navarro), Servicio de Medicina Interna, Requena, Valencia, Spain.

Correspondence to: Juan José Soler-Cataluña, MD, Unidad de Neumologyía, Servicio de Medicina Interna, Hospital General de Requena, Paraje Casablanca s/n, 46340 Requena, Valencia, Spain; e-mail: soler juacat@gva.es



Chest. 2005;128(4):2108-2115. doi:10.1378/chest.128.4.2108
Text Size: A A A
Published online

Background: A low body mass index (BMI) has been shown to be an independent indicator of poor prognosis in patients with COPD. However, some studies suggest that muscle mass depletion (MD) is the main factor responsible for the negative effects attributable to malnutrition.

Study objective: To evaluate the prognostic influence of MD estimated from anthropometric parameters.

Design and measurements: Mortality was studied in a prospective cohort of 96 male patients with COPD (average age, 69 ± 9 years; FEV1 percentage of predicted, 44 ± 18% [ ± SD]) followed up for 3 years, with an evaluation of the prognostic influence of the following anthropometric parameters: BMI, mid-arm muscle area (MAMA), and fat-free mass index. Other risk factors were also analyzed, such as age, comorbidity (Charlson index), basal dyspnea index, the St. George’s Respiratory Questionnaire score, the number of hospital admissions in the year prior to nutritional evaluation, the number of hospital admissions in the year immediately after nutritional evaluation (Hpost), spirometry, and blood gases.

Results: In the multivariate study, Paco2 (p = 0.003; hazard ratio, 1.08), Hpost (p = 0.005, hazard ratio, 4.63), and a MAMA value less than or equal to percentile 25 of the reference value (p25) [p = 0.025; hazard ratio, 3.78] were found to be independent indicators of poor prognosis. Respiratory mortality after 12, 24, and 36 months in the patients with MAMA ≤ p25 was 12.1%, 31.4%, and 39.2%, respectively, vs 5.9%, 7.9%, and 13% in the group of patients without MD (p = 0.006). In normal-weight or overweight patients, MAMA ≤ p25 increased the risk of mortality 3.4-fold (p = 0.032).

Conclusions: MD is a better predictor of mortality than BMI in patients with COPD, fundamentally in normal-weight or overweight patients. The prognostic influence of MD can be estimated indirectly by determining the MAMA, an inexpensive, simple, and rapidly obtained anthropometric measure.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543